Biotech Showcase™ 2017: PhaseRx makes more noise than silence with mRNA delivery

January 24, 2017
Having ditched RNA silencing in 2012, PhaseRx president and CEO Dr. Robert Overell explains to Mike Ward, global director of content at Informa Pharma Intelligence’s insights portfolio, how delivering messenger RNA inside diseased cells may revolutionize and grow the current USD 4 billion enzyme replacement market.
Previous Video
Biotech Showcase™ 2017: ProNAI defects from oligos to DDR as Sierra Oncology
Biotech Showcase™ 2017: ProNAI defects from oligos to DDR as Sierra Oncology

Sierra Oncology president and CEO Dr. Nick Glover tells Mike Ward, Informa Pharma Intelligence insight glob...

Next Video
Biotech Showcase™ 2017: Second Genome CEO predicts paradigm shift with microbiome discovery
Biotech Showcase™ 2017: Second Genome CEO predicts paradigm shift with microbiome discovery

Microbiome discovery and development will trigger the next major paradigm shift in medicine, more profound ...